178 related articles for article (PubMed ID: 22320912)
1. Bone marrow-derived proangiogenic cells in pancreatic cancer.
Mizukami Y
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():23-6. PubMed ID: 22320912
[TBL] [Abstract][Full Text] [Related]
2. Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma.
Craven KE; Gore J; Korc M
Cancer Lett; 2016 Oct; 381(1):201-10. PubMed ID: 26723874
[TBL] [Abstract][Full Text] [Related]
3. Hedgehog signaling and pancreatic tumor development.
Lauth M; Toftgård R
Adv Cancer Res; 2011; 110():1-17. PubMed ID: 21704226
[TBL] [Abstract][Full Text] [Related]
4. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model.
Guimaraes AR; Rakhlin E; Weissleder R; Thayer SP
Pancreas; 2008 Nov; 37(4):440-4. PubMed ID: 18953259
[TBL] [Abstract][Full Text] [Related]
7. Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumors.
Sasajima J; Mizukami Y; Sugiyama Y; Nakamura K; Kawamoto T; Koizumi K; Fujii R; Motomura W; Sato K; Suzuki Y; Tanno S; Fujiya M; Sasaki K; Shimizu N; Karasaki H; Kono T; Kawabe J; Ii M; Yoshiara H; Kamiyama N; Ashida T; Bardeesy N; Chung DC; Kohgo Y
Cancer Res; 2010 Aug; 70(15):6283-92. PubMed ID: 20631070
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenesis therapy in pancreatic carcinoma.
Saif MW
JOP; 2006 Mar; 7(2):163-73. PubMed ID: 16525200
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
[TBL] [Abstract][Full Text] [Related]
10. Early requirement of Rac1 in a mouse model of pancreatic cancer.
Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
[TBL] [Abstract][Full Text] [Related]
11. Agents targeting the Hedgehog pathway for pancreatic cancer treatment.
Bisht S; Brossart P; Maitra A; Feldmann G
Curr Opin Investig Drugs; 2010 Dec; 11(12):1387-98. PubMed ID: 21154121
[TBL] [Abstract][Full Text] [Related]
12. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
Bockhorn M; Tsuzuki Y; Xu L; Frilling A; Broelsch CE; Fukumura D
Clin Cancer Res; 2003 Sep; 9(11):4221-6. PubMed ID: 14519649
[TBL] [Abstract][Full Text] [Related]
13. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts.
Holloway SE; Beck AW; Shivakumar L; Shih J; Fleming JB; Brekken RA
Ann Surg Oncol; 2006 Aug; 13(8):1145-55. PubMed ID: 16791450
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional anti-angiogenesis therapy of human pancreatic cancer.
Xie K; Wei D; Huang S
Cytokine Growth Factor Rev; 2006 Jun; 17(3):147-56. PubMed ID: 16516532
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells.
Nakamura K; Sasajima J; Mizukami Y; Sugiyama Y; Yamazaki M; Fujii R; Kawamoto T; Koizumi K; Sato K; Fujiya M; Sasaki K; Tanno S; Okumura T; Shimizu N; Kawabe J; Karasaki H; Kono T; Ii M; Bardeesy N; Chung DC; Kohgo Y
PLoS One; 2010 Jan; 5(1):e8824. PubMed ID: 20098680
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
Fukasawa M; Korc M
Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H
Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma.
Bausch D; Pausch T; Krauss T; Hopt UT; Fernandez-del-Castillo C; Warshaw AL; Thayer SP; Keck T
Angiogenesis; 2011 Sep; 14(3):235-43. PubMed ID: 21442180
[TBL] [Abstract][Full Text] [Related]
19. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
